Sintilimab in Combination with Chemotherapy ± Local Treatment for Om-G/GEJ
Clinical trial NCT06739161 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06739161
- Sponsor
- Jiangsu Cancer Institute & Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-02
- Primary completion
- 2027-12-02
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.